 |
|
Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis
Chia-Ling Yu, Fu-Chi Yang, Szu-Nian Yang, Ping-Tao Tseng, Brendon Stubbs, Ta-Chuan Yeh, Chih-Wei Hsu, Dian-Jeng Li, Chih-Sung Liang
Psychiatry Investig. 2021;18(10):958-967. Published online 2021 Oct 8 DOI: https://doi.org/10.30773/pi.2021.0209
|
|
Substrate recognition by the 4‐hydroxytryptamine kinase PsiK in psilocybin biosynthesis
Kai Rogge, Tobias Johannes Wagner, Dirk Hoffmeister, Bernhard Rupp, Sebastiaan Werten
FEBS Letters.2025; 599(3): 447. CrossRef Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review
Ana Esteves Ferreira, Paulo Reis-Pina
Journal of Psychosomatic Research.2025; 189: 112020. CrossRef Observational cohort study of a group-based VR program to improve mental health and wellbeing in people with life-threatening illnesses
Hannes Kettner, David R. Glowacki, Justin Wall, Robin L. Carhart-Harris, Leor Roseman, Joseph L. Hardy
Frontiers in Virtual Reality.2025;[Epub] CrossRef Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
Daniel Kinderlehrer
Neuropsychiatric Disease and Treatment.2025; Volume 21: 141. CrossRef Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis
Maria Helha Fernandes-Nascimento, Karine Viana-Ferreira, André Brooking Negrão
Psychedelic Medicine.2025;[Epub] CrossRef A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress
Fejzic Dino
Cureus.2025;[Epub] CrossRef Ayahuasca Retreats: The Role of Awe and Mystical Experiences in Well-Being
Brant Maclean, Amy Wilson, Andrew Allen, Vikki Schaffer, Lee Kannis-Dymand
Journal of Psychoactive Drugs.2025; : 1. CrossRef The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, Josimar Hernandez Antonio, Philip A. Bonanno, Carolyn MacLeod, Charlotte Pierce, Hunter Carney, Morgan T. Morrison, Charles Saylor, George Danias, Lauren Lepow, Rachel Yehuda
Current Neuropharmacology.2024; 22(4): 636. CrossRef Psychedelic Therapy: A Primer for Primary Care Clinicians—3,4-Methylenedioxy-methamphetamine (MDMA)
Kenneth Shinozuka, Burton J. Tabaac, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir
American Journal of Therapeutics.2024; 31(2): e141. CrossRef Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin
Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir
American Journal of Therapeutics.2024; 31(2): e121. CrossRef Methyl transfer in psilocybin biosynthesis
Jesse Hudspeth, Kai Rogge, Sebastian Dörner, Maximilian Müll, Dirk Hoffmeister, Bernhard Rupp, Sebastiaan Werten
Nature Communications.2024;[Epub] CrossRef Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy
Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, Nicolas Garel, Shannon Dames, Ryan Patchett-Marble, Soham Rej, Sara Gloeckler, David Erritzoe, Robin Carhart-Harris, Kyle T. Greenway
Scientific Reports.2024;[Epub] CrossRef Psilocybin for clinical indications: A scoping review
Kim Madden, Breanne Flood, Darren Young Shing, Michael Ade-Conde, Imad Kashir, Melanie Mark, James MacKillop, Mohit Bhandari, Anthony Adili
Journal of Psychopharmacology.2024; 38(10): 839. CrossRef Less is more? A review of psilocybin microdosing
Isabella A Savides, Kim Outhoff
Journal of Psychopharmacology.2024; 38(10): 846. CrossRef Psilocybin for major depressive disorder: a systematic review of randomized controlled studies
Li-Juan Li, Yu Mo, Zhan-Ming Shi, Xing-Bing Huang, Yu-Ping Ning, Hua-Wang Wu, Xin-Hu Yang, Wei Zheng
Frontiers in Psychiatry.2024;[Epub] CrossRef Neuroprotective effects of psilocybin in a rat model of stroke
Seong-Jin Yu, Kuo-Jen Wu, Yu-Syuan Wang, Eunkyung Bae, Fabio Chianelli, Nicholas Bambakidis, Yun Wang
BMC Neuroscience.2024;[Epub] CrossRef Equipos de salud mental de enlace en el hospital oncológico: una apuesta hacia la transdisciplinariedad
Adriana Marcela Prada, Andrés Felipe Jiménez-Mora, Juanita Rojas Restrepo
Medicina.2024; 46(2): 537. CrossRef Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, Andrew Holmes
Neuropharmacology.2023; 226: 109418. CrossRef Are psychedelics the answer to chronic pain: A review of current literature
Nina I. Kooijman, Tim Willegers, Anke Reuser, Wim M. Mulleners, Cornelis Kramers, Kris C. P. Vissers, Selina E. I. van der Wal
Pain Practice.2023; 23(4): 447. CrossRef The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study
Daniel A Kinderlehrer
International Medical Case Reports Journal.2023; Volume 16: 109. CrossRef The need for establishing best practices and gold standards in psychedelic medicine
Allison Feduccia, Gabby Agin-Liebes, Collin M. Price, Nicole Grinsell, Summer Paradise, David M. Rabin
Journal of Affective Disorders.2023; 332: 47. CrossRef Psilocybin in Palliative Care: An Update
Emily Whinkin, Moira Opalka, Conor Watters, Atara Jaffe, Sunil Aggarwal
Current Geriatrics Reports.2023; 12(2): 50. CrossRef Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review
Oliver Rumle Hovmand, Emil Deleuran Poulsen, Sidse Arnfred, Ole Jakob Storebø
Journal of Psychopharmacology.2023; 37(7): 649. CrossRef Psilocybin Use in Palliative Care #464
Mark D. Sims, John M. Hendrick
Journal of Palliative Medicine.2023; 26(9): 1287. CrossRef Expectancies for Subjective and Antidepressant Effects in Psilocybin Users
Mitch Earleywine, Maha N. Mian, Joseph A. De Leo
Journal of Humanistic Psychology.2023;[Epub] CrossRef
|